Living with Neuroendocrine Tumors
People with neuroendocrine tumors can lead meaningful, active, productive lives. Learn how you can make the most of every day.
made one or more lifestyle changes due to NETs2
0
%
report general fatigue/muscle weakness2
0
%
experienced diarrhea2
0
%
The latest in NETRF News
GLP-1 Drugs and Neuroendocrine Cancer: What a New Study Suggests
By Anna Greene, PhD, NETRF Chief Scientific Officer Drugs like Ozempic®, Wegovy®, and Mounjaro®, known
Looking Ahead: Hope, Discovery, and Momentum from the 2025 NETRF Research Symposium
By Anna Greene, PhD, NETRF Chief Scientific Officer Each year, the Margie & Robert E.
NETRF Research News October 2025
NETRF recently released its Research Roadmap, outlining a bold plan to transform care for neuroendocrine cancers.
Attend a NET patient conference
Find support groups in your area
Check out patient advocacy groups
2Singh S, Granberg D, Wolin E, et al. Patient-reported burden of a neuroendocrine tumor (NET) diagnosis: results from the first global survey of patients with NETs. J Glob Oncol. 2016;2(1):43-53.